Teniposide (VM-26) as a single drug trea
β
Petre N. Grozea; John J. Crowley; Vikki A. Canfield; Laura Kingsbury; S. William
π
Article
π
1997
π
John Wiley and Sons
π
English
β 74 KB
π 3 views
## Background: Teniposide (vm-26) was reported to have activity in small cell lung carcinoma (sclc). the authors performed a phase ii study of teniposide as a treatment for patients with previously untreated extensive sclc. ## Methods: The study was open to patients with a histologic or cytologic